Srinivas Murthy to Coronavirus Infections
This is a "connection" page, showing publications Srinivas Murthy has written about Coronavirus Infections.
Connection Strength
0.223
-
The authors reply. Pediatr Crit Care Med. 2020 11; 21(11):1023.
Score: 0.028
-
The authors reply. Pediatr Crit Care Med. 2020 08; 21(8):783-784.
Score: 0.028
-
Coronavirus Disease 2019 in Critically Ill Children: A Narrative Review of the Literature. Pediatr Crit Care Med. 2020 07; 21(7):662-666.
Score: 0.028
-
Care for Critically Ill Patients With COVID-19. JAMA. 2020 Apr 21; 323(15):1499-1500.
Score: 0.027
-
Generating randomized trial evidence to optimize treatment in the COVID-19 pandemic. CMAJ. 2020 Apr 14; 192(15):E405-E407.
Score: 0.027
-
CMAJ. 2020 10 26; 192(43):E1323-E1333.
Score: 0.007
-
A national cross-sectional survey of public perceptions of the COVID-19 pandemic: Self-reported beliefs, knowledge, and behaviors. PLoS One. 2020; 15(10):e0241259.
Score: 0.007
-
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. JAMA. 2020 10 06; 324(13):1330-1341.
Score: 0.007
-
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial. JAMA. 2020 10 06; 324(13):1317-1329.
Score: 0.007
-
Corticosteroid therapy for critically ill patients with COVID-19: A structured summary of a study protocol for a prospective meta-analysis of randomized trials. Trials. 2020 Aug 24; 21(1):734.
Score: 0.007
-
Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial. Clin Trials. 2020 10; 17(5):491-500.
Score: 0.007
-
Drug treatments for covid-19: living systematic review and network meta-analysis. BMJ. 2020 07 30; 370:m2980.
Score: 0.007
-
Remdesivir for severe covid-19: a clinical practice guideline. BMJ. 2020 07 30; 370:m2924.
Score: 0.007
-
The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and Design. Ann Am Thorac Soc. 2020 07; 17(7):879-891.
Score: 0.007
-
High-flow nasal cannula for acute hypoxemic respiratory failure in patients with COVID-19: systematic reviews of effectiveness and its risks of aerosolization, dispersion, and infection transmission. Can J Anaesth. 2020 09; 67(9):1217-1248.
Score: 0.007
-
Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline. CMAJ. 2020 05 19; 192(20):E536-E545.
Score: 0.007
-
COVID-19: a novel coronavirus and a novel challenge for critical care. Intensive Care Med. 2020 05; 46(5):833-836.
Score: 0.007